The sodium channel blocker market is expanding due to the increasing prevalence of neuropathic pain and the demand for more selective treatments like ...

Annual Meeting Clinical Trials Plenary Session, Sanofi presented data on tolebrutinib in patients with non-relapsing ...

Diakonos Oncology, a clinical-stage biotechnology company developing innovative immunotherapies for difficult-to-treat cancers, today announced the successful presentation of an abstract at the 2025 ...

Jeffrey Howard, associate professor of public health at UTSA, Alicia Swan, director of rehabilitation research at the U.S. Department of Veterans Affairs, and Sara Mithani, assistant professor at the ...